Review of treatment options for oligometastatic non–small cell lung cancer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Our understanding of metastatic disease is constantly evolving. Although outcomes for patients with stage IV non–small cell lung cancer (NSCLC) are poor, aggressive/radical local intervention may be effective in a subset of patients with limited or “oligometastatic” disease. Here we review and compare the range of available treatment options that are specific to oligometastatic NSCLC, and discuss potential directions of future clinical research.

Original languageEnglish (US)
Pages (from-to)186-193
Number of pages8
JournalClinical Advances in Hematology and Oncology
Volume13
Issue number3
StatePublished - 2015

Fingerprint

Non-Small Cell Lung Carcinoma
Therapeutics
Research
Direction compound

Keywords

  • Limited metastatic disease
  • Non–small cell lung cancer
  • Oligometastases
  • Stereotactic radiation

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

@article{3236cce85d114a668f73c25d48a8a787,
title = "Review of treatment options for oligometastatic non–small cell lung cancer",
abstract = "Our understanding of metastatic disease is constantly evolving. Although outcomes for patients with stage IV non–small cell lung cancer (NSCLC) are poor, aggressive/radical local intervention may be effective in a subset of patients with limited or “oligometastatic” disease. Here we review and compare the range of available treatment options that are specific to oligometastatic NSCLC, and discuss potential directions of future clinical research.",
keywords = "Limited metastatic disease, Non–small cell lung cancer, Oligometastases, Stereotactic radiation",
author = "Folkert, {Michael R.} and Robert Timmerman",
year = "2015",
language = "English (US)",
volume = "13",
pages = "186--193",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "3",

}

TY - JOUR

T1 - Review of treatment options for oligometastatic non–small cell lung cancer

AU - Folkert, Michael R.

AU - Timmerman, Robert

PY - 2015

Y1 - 2015

N2 - Our understanding of metastatic disease is constantly evolving. Although outcomes for patients with stage IV non–small cell lung cancer (NSCLC) are poor, aggressive/radical local intervention may be effective in a subset of patients with limited or “oligometastatic” disease. Here we review and compare the range of available treatment options that are specific to oligometastatic NSCLC, and discuss potential directions of future clinical research.

AB - Our understanding of metastatic disease is constantly evolving. Although outcomes for patients with stage IV non–small cell lung cancer (NSCLC) are poor, aggressive/radical local intervention may be effective in a subset of patients with limited or “oligometastatic” disease. Here we review and compare the range of available treatment options that are specific to oligometastatic NSCLC, and discuss potential directions of future clinical research.

KW - Limited metastatic disease

KW - Non–small cell lung cancer

KW - Oligometastases

KW - Stereotactic radiation

UR - http://www.scopus.com/inward/record.url?scp=84925399995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925399995&partnerID=8YFLogxK

M3 - Article

C2 - 26352427

AN - SCOPUS:84925399995

VL - 13

SP - 186

EP - 193

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 3

ER -